ARCHIVES

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

More Minorities, Women, Fewer MD On Study Sections

September 2, 1988

Reauthorization Still Held up

September 30, 1988

In Brief: HEW Opposes Research Contract Peer review; Congressman Blass Inadequate Grant Funds

May 10, 1974

Senate Votes Down Attempt to Cut NCI Funds $100 Million

October 3, 1975

Lung Cancer Prevention Diet Study Concept Tabled By DCPC Board

February 8, 1985

In Brief: Gertrude Elion, Nobel Laureae Whose Work Led To New Drugs For Cancer, Dead at 81

February 26, 1999